Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dichlorphenamide versus placebo in periodic paralysis
2008-002306-19Phase 3Completed
- Sponsor
- University of Rochester
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in familial periodic paralysis (PP), hyperkalemic periodic paralysis (HyperKPP) and hypokalemic periodic paralysis (HypoPP) comparing Dichlorphenamide with Placebo (2 arms). Primary endpoints: Attack frequency of weakness and Acute worsening in hypokalemic periodic paralysis. Started Mar 2010; status: completed.
02
Drugs
dichlorphenamide
03
Conditions
familial periodic paralysis (PP)hyperkalemic periodic paralysis (HyperKPP)hypokalemic periodic paralysis (HypoPP)
Beyond the preview
Go deeper on 2008-002306-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002306-19.